Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Xphyto Therapeutics Corp (XPHY.CN)

Xphyto Therapeutics Corp (XPHY.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
XPhyto, Biosensors Market and Product Developments on Platform-Based Oral Dissolvable Biosensors for Oral Health and Infectious Disease AccessWire - Mon Apr 11, 2022

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / April 11, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to provide a market and product...

XPHY.CN : 0.510 (-3.77%)
XPHYF : 0.2836 (-31.13%)
InvestorNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Completes Transformative Step in Commercial Strategy with 3a Acquisition Investor Brand Network - Mon Dec 6, 2021

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities,...

XPHY.CN : 0.510 (-3.77%)
XPHYF : 0.2836 (-31.13%)
XPhyto Completes Strategic Acquisition of 3a-diagnostics GmbH AccessWire - Mon Dec 6, 2021

- The acquisition positions XPhyto to be a leading Biosensor producer integrating thin film technology with 3a-diagnostics biosensor technology - The acquisition of 3a, a German-based rapid point-of-care...

XPHY.CN : 0.510 (-3.77%)
XPHYF : 0.2836 (-31.13%)
XPhyto Therapeutics Announces Stock Option Grants AccessWire - Fri Dec 3, 2021

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / December 3, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT)...

XPHY.CN : 0.510 (-3.77%)
XPHYF : 0.2836 (-31.13%)
XPhyto Therapeutics Closes Private Placements for Gross Proceeds of $7,000,0000 AccessWire - Fri Nov 26, 2021

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / November 26, 2021 / XPhyto Therapeutics Corp. ("XPhyto" or the "Company") (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT)...

XPHY.CN : 0.510 (-3.77%)
XPHYF : 0.2836 (-31.13%)
InvestorNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Appoints New CFO Investor Brand Network - Mon Nov 22, 2021

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, has named a new chief financial officer: Joseph Meagher. A chartered...

XPHY.CN : 0.510 (-3.77%)
XPHYF : 0.2836 (-31.13%)
XPhyto Announces CFO Appointment AccessWire - Fri Nov 19, 2021

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / November 19, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the appointment of...

XPHY.CN : 0.510 (-3.77%)
XPHYF : 0.2836 (-31.13%)
DTC.CN : 1.4700 (-9.26%)
Q4 Investor Summit Small Cap & Micro Cap Conference To Offer Opportunity to Meet with C-level Management of 90+ Companies Investor Brand Network - Mon Nov 15, 2021

Small and Micro-cap investors are invited to attend the Q4 Investor Summit being held on November 16-17, 2021. The event is organized by the Investor Summit Group, recognised as a highly reputed brand...

AZ.TO : 6.19 (unch)
AAZZF : 10.8545 (+0.13%)
ACST : 2.96 (-2.31%)
ATNM : 8.96 (+2.40%)
ADCO.TO : 0.2450 (unch)
ADCOF : 0.1825 (+0.39%)
ALIM : 3.65 (+4.89%)
ACOGF : 0.5000 (unch)
AMST : 3.31 (-4.06%)
ANVS : 5.18 (-4.95%)
ANPC : 4.37 (-5.41%)
ARC : 2.68 (-1.11%)
XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) Featured in Coverage of Investor Summit Group’s Q4 Virtual Event Investor Brand Network - Wed Nov 10, 2021

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities, including:...

XPHY.CN : 0.510 (-3.77%)
XPHYF : 0.2836 (-31.13%)
XPhyto Announces Managing Director Appointment, Financing and 3a-diagnostics Development AccessWire - Wed Nov 3, 2021

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / November 3, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT)...

XPHY.CN : 0.510 (-3.77%)
XPHYF : 0.2836 (-31.13%)

Barchart Exclusives

2 Uranium Stocks With 50% or More Upside Potential Barchart - Sat May 4, 8:15AM CDT
As U.S. passes the bill to ban uranium import from Russia, U.S. based uranium companies are sure to enjoy the increased demand. Here are 2 stocks with upside according to analysts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot